Latest Insights
Gilead’s $11.5B Bet: What Two Companies Saw in One Week
Gilead and UCB deployed $3B+ on similar autoimmune drugs within days. What this pharmaceutical investment convergence signals for institutional...
Is Women’s Health a Good Investment Opportunity for Private Wealth?
$124 trillion is transferring to women. Women's health receives 6% of healthcare investment. These are not two separate facts....
The Future of Healthcare Innovation
How aging populations, rising costs, and institutional inertia quietly reshaped medicine into one of the largest sectors of the...
Latest Insights
Gilead’s $11.5B Bet: What Two Companies Saw in One Week
Gilead and UCB deployed $3B+ on similar autoimmune drugs within days. What this pharmaceutical investment convergence signals for institutional...
Is Women’s Health a Good Investment Opportunity for Private Wealth?
$124 trillion is transferring to women. Women's health receives 6% of healthcare investment. These are not two separate facts....
The Future of Healthcare Innovation
How aging populations, rising costs, and institutional inertia quietly reshaped medicine into one of the largest sectors of the...